Ann Bielser Woodside, BA, CCRP

*** ******* ** *** *

Springfield, IL 62704

217-***-****

acc5ma@r.postjobfree.com

Education

****-**** ****** ******* **** School, Mason City, IL

****-**** *******h College, Monmouth, IL-Earned B.A. in Biopsychology, Cum

Laude and Departmental Honors

Undergraduate Research Experience

2005-2006 The Effects of Nicotine Withdrawal on Attention and Mood-Monmouth

College-Awarded a PsiChi International Honor Society in Psychology

Undergraduate Research Grant

Clinical Research Experience

May 2010- present Clinical Research Coordinator, Springfield Clinic, Department of

Clinical Research, Springfield, IL

Certifications

May 2010-present CITI Good Clinical Practice

May 2010-present CITI Institutional Review Board

May 2010-present IATA Dangerous Goods Regulations

July 2010-present American Heart Association CPR

July 2012-present SoCRA Certified Clinical Research Professional

Memberships

October 2010-present Allied Health Professional- Memorial Hospital, Springfield, IL

November2010-present Allied Health Professional- St. John?s Hospital, Springfield, IL

November 2011-present SoCRA

Clinical Research Protocols

2010 Daiichi- Atrial fibrillation Anticoagulation- Phase III-Data Entry (closed)

2010 Novartis- Moderate to Severe Chronic Plaque-type Psoriasis- Phase II-Unblinded

Pharmacist (closed)

2010 Novartis- Moderate to Severe Chronic Plaque-type Psoriasis (extension trial)-

Unblinded Pharmacist (closed)

2010 Genomic Health, Inc- Breast Cancer Oncotype Registry- Pilot Phase- Study

Coordinator (closed)

2010 Alcon- MPS in Symptomatic Contact Lens Wearers- Device ?Lead Study

Coordinator (closed)

2010 Bristol Meyer Squibb- Metastatic Prostate Cancer- Phase II- Study Coordinator

(closed)

2010 Vivus- Erectile Dysfunction Following Bilateral Nerve-Sparing Prostatectomy-

Phase III- Recruitment (closed)

2010 Pfizer- Overactive Bladder- Phase IV- Study Coordinator (closed)

2010 Lilly- Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and

Neck- Phase II- Study Coordinator (closed)

2010 Wyeth/Pfizer/Puma- Early Stage HER-2/neu Amplified Breast Cancer- Phase III-

Study Coordinator (follow up)

2010 Wyeth/Pfizer/Puma- ErbB-2 Positive Recurrent/Metastatic Breast Cancer- Phase

III- Study Coordinator (follow up)

2010 Medtronic- Urinary Urge Incontinence/Urinary Frequency- Interstim Device-

Lead Study Coordinator (follow up)

2011 Lilly- Stage IV Non-small Cell Lung Cancer- Phase III- Study Coordinator

(closed)

2011 Genentech, Inc- Chronic Idiopathic Urticaria- Phase II ? Unblinded Pharmacist

(closed)

2011 Warner Chilcott- Vulvovaginal Atrophy in Post-menopausal Women- Phase III-

Study Coordinator (closed)

2011 Warner Chilcott- Vulvovaginal Atrophy in Post-menopausal Women (extension)-

Lead Study Coordinator (closed)

2011 GTx- Non-Metestatic Prostate Cancer- Phase II- Study Coordinator (closed)

2011 Epigenomics- Specimen Collection/Colorectal Cancer- Septin 9 Assay- Study

Coordinator (closed)

2011 Astellas- Metastatic Prostate Cancer- Phase II- Lead Study Coordinator (follow

up)

2011 AMAG- Iron Deficiency Anemia- Phase III- Lead Study Coordinator (closed)

2012 AMAG- Iron Deficiency Anemia (extension trial)- Lead Study Coordinator

(closed)

2012 Novartis- Moderate to Severe Chronic Plaque-type Psoriasis- Phase III-

Unblinded Pharmacist (enrolling)

2012 Integra- Diabetic Foot Ulcer- IDRT Device- Lead Study Coordinator (closed)

2012 Astellas- Urinary Incontinence Following Robotic Assisted Radical

Prostatectomy- Phase IV- Lead Study Coordinator (closed)

2012 Merck- C. difficile infection- Phase III- Unblinded Pharmacist (enrolling)

2012 Epigenomics- Specimen Collection/Colorectal Cancer- Epi proColon and Fecal

Immunochemical Test- Study Coordinator (closed)

2013 Merck- Moderate to Severe Chronic Plaque Psoriasis- Phase 3- Lead Study

Coordinator (enrolling)

2013 Warner Chilcott- Lower Urinary Tract Symptoms Secondary to Benign Prostatic

Hyperplasia- Phase 2- Lead Study Coordinator (closed)

2013 AbbVie- Heavy Menstrual Bleeding Associated with Uterine Fibroids- Phase 2-

Lead Study Coordinator (enrolling)

2014 Novo Nordisk- Diabetes Mellitus Type II- Phase 3- Study Coordinator (enrolling)

Updated 19FEB2014

Contact this candidate